Compare SHASUN PHARMA with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ORCHID PHARMA - Comparison Results

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ORCHID PHARMA SHASUN PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 123.9 -118.4 - View Chart
P/BV x 8.5 34.0 25.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ORCHID PHARMA
Sep-13
SHASUN PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs94194 48.6%   
Low Rs4635 130.3%   
Sales per share (Unadj.) Rs214.2276.5 77.5%  
Earnings per share (Unadj.) Rs5.3-79.2 -6.7%  
Cash flow per share (Unadj.) Rs15.8-43.5 -36.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.353.9 98.9%  
Shares outstanding (eoy) m56.6270.45 80.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 78.8%   
Avg P/E ratio x13.1-1.4 -906.2%  
P/CF ratio (eoy) x4.4-2.6 -167.7%  
Price / Book Value ratio x1.32.1 61.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9588,067 49.1%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1642,527 85.6%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m12,12719,477 62.3%  
Other income Rs m229407 56.3%   
Total revenues Rs m12,35619,884 62.1%   
Gross profit Rs m1,0091,103 91.5%  
Depreciation Rs m5942,519 23.6%   
Interest Rs m4155,227 7.9%   
Profit before tax Rs m230-6,236 -3.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-73-125 58.1%   
Profit after tax Rs m302-5,580 -5.4%  
Gross profit margin %8.35.7 147.0%  
Effective tax rate %-31.72.0 -1,576.9%   
Net profit margin %2.5-28.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m6,88411,014 62.5%   
Current liabilities Rs m8,45632,060 26.4%   
Net working cap to sales %-13.0-108.1 12.0%  
Current ratio x0.80.3 237.0%  
Inventory Days Days6295 65.0%  
Debtors Days Days10834 320.5%  
Net fixed assets Rs m4,97029,440 16.9%   
Share capital Rs m113705 16.1%   
"Free" reserves Rs m2,8752,043 140.7%   
Net worth Rs m3,0203,800 79.5%   
Long term debt Rs m1,8179,018 20.2%   
Total assets Rs m13,34746,510 28.7%  
Interest coverage x1.6-0.2 -804.3%   
Debt to equity ratio x0.62.4 25.4%  
Sales to assets ratio x0.90.4 217.0%   
Return on assets %5.4-0.8 -707.0%  
Return on equity %10.0-146.9 -6.8%  
Return on capital %13.3-3.7 -356.7%  
Exports to sales %46.437.9 122.4%   
Imports to sales %14.222.6 63.0%   
Exports (fob) Rs m5,6227,378 76.2%   
Imports (cif) Rs m1,7284,406 39.2%   
Fx inflow Rs m5,8437,513 77.8%   
Fx outflow Rs m2,1735,649 38.5%   
Net fx Rs m3,6691,865 196.8%   
CASH FLOW
From Operations Rs m3981,682 23.6%  
From Investments Rs m-1,635-9,860 16.6%  
From Financial Activity Rs m1,3096,644 19.7%  
Net Cashflow Rs m71-1,535 -4.6%  

Share Holding

Indian Promoters % 39.2 32.3 121.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.6 78.3%  
FIIs % 17.6 3.3 533.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 39.6 55.3 71.6%  
Shareholders   20,750 84,811 24.5%  
Pledged promoter(s) holding % 12.3 54.9 22.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   SUVEN LIFE SCIENCES  NEULAND LABS  SANOFI INDIA  TTK HEALTHCARE  SUN PHARMA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS